These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 19016259)
1. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. Chua TC; Yan TD; Morris DL J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259 [TBL] [Abstract][Full Text] [Related]
2. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159 [TBL] [Abstract][Full Text] [Related]
3. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150 [TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma. Tudor EC; Chua TC; Liauw W; Morris DL Am Surg; 2010 Apr; 76(4):400-5. PubMed ID: 20420251 [TBL] [Abstract][Full Text] [Related]
6. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682 [TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562 [TBL] [Abstract][Full Text] [Related]
8. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234 [TBL] [Abstract][Full Text] [Related]
9. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859 [TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Yano H; Moran BJ; Cecil TD; Murphy EM Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109 [TBL] [Abstract][Full Text] [Related]
11. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335 [TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Yan TD; Morris DL Ann Surg; 2008 Nov; 248(5):829-35. PubMed ID: 18948811 [TBL] [Abstract][Full Text] [Related]
13. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401 [TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392 [TBL] [Abstract][Full Text] [Related]
15. Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma. Saxena A; Chua TC Lung Cancer; 2009 Nov; 66(2):269-70. PubMed ID: 19733416 [No Abstract] [Full Text] [Related]
16. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. Sugarbaker PH; Chang D Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456 [TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis. Salti GI; Ailabouni L; Undevia S Ann Surg Oncol; 2012 May; 19(5):1410-5. PubMed ID: 22302269 [TBL] [Abstract][Full Text] [Related]
18. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042 [TBL] [Abstract][Full Text] [Related]
19. [Updated treatment of peritoneal carcinomas: a review]. Deraco M; Laterza B; Kusamura S; Baratti D Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656 [TBL] [Abstract][Full Text] [Related]
20. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Chua TC; Morris DL; Esquivel J Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]